Testing effectiveness (Phase 2)UnknownNCT03145220
What this trial is testing
Immunomodulation of EA-230 Following On-pump Coronary Artery Bypass Grafting (CABG)
Who this might be right for
Systemic Inflammatory Response SyndromeCoronary Artery Bypass Grafting
Radboud University Medical Center 180